Abstract submission is closed.

Get a chance to present your research at MEHFC 2024 and give it the exposure it deserves, also end up gathering invaluable feedback on your findings. Attendees can provide and add insights that give different perspective on your study.

Abstracts are submitted online through oral/poster formats. Abstracts will be reviewed, and accepted submissions will be presented at the conference.

Guidelines for submitting an abstract :

  • 22 August 2023

    Abstract Submissions Open (Oral/Poster)

  • 15 November 2023

    Abstracts Submissions Close (Oral/Poster)

  • 30 November 2023

    Author Notifications (Oral/Poster)

A special criterion for accepting abstracts will be their topic as well as structure, content and degree of innovation.

  • Please note that a maximum of 300 words is permitted. The titles and the names of the authors are excluded from this number and have to be entered separately. Tables should not be included in the abstract body.
  • Methods section should include type of statistical analysis done if applicable to the study.
  • Statements like “Results will be discussed” are not acceptable and may lead to a rejection of the abstract.

The scientific committee will accept abstracts based on their relevance and quality, structure, content and degree of innovation.

Abstract Topics :

  • Biomarkers / Neurohormones
  • Cardiovascular Pharmacology
  • Cardiovascular Imaging
  • Cardiovascular Interventions
  • Electrophysiology / Arrhythmias
  • Epidemiology / Prevention
  • Management Strategies / Adherence
  • Quality of Care / Outcomes
  • Surgery / Transplantation / Devices
  • Case Reports
  • Regional Studies and Registries
  • International Studies and Registries

Structure of the Abstract for Oral and Poster Presentations

  • Background and Purpose
  • Methods
  • Results
  • Conclusions

Reivew Criteria

  • Language/Format
  • Relevance/Originality
  • Overall Scientific Quality

Abstract Delivery Notification

Authors will be notified about the delivery of their abstract by e-mail immediately. In case you do not receive confirmation within 24 hours, please check your spam folder. In case of no confirmation e-mail, please contact: registration@me-heartfailure.com

Author Agreement :

By submitting the abstract, the author confirms and agrees to the following:

  1. All authors approve submitting this work for presentation.
  2. The authors have done the work reported in the abstract and take full responsibility for the contents.
  3. The authors transfer all copyright ownership of the abstract to MEHFC 2024.
  4. The authors agree to confine their presentation to information in the abstract.
  5. At least one author will be available to present the abstract if selected for the program.
  6. The author will immediately notify the MEHFC 2024 Scientific Committee if they are unable to make a presentation or if the presenting author must be changed.
  7. The authors guarantee that clinical studies and any animal tests have proceeded with the official permission from the proper authorities.
  8. All presenters will be responsible for their own registration fees, hotel and travel expenses. We regret that we cannot waive registration fees or cover expenses for any oral or poster presenters.